MA26496A1 - Combinaisons anti-virales. - Google Patents

Combinaisons anti-virales.

Info

Publication number
MA26496A1
MA26496A1 MA25076A MA25076A MA26496A1 MA 26496 A1 MA26496 A1 MA 26496A1 MA 25076 A MA25076 A MA 25076A MA 25076 A MA25076 A MA 25076A MA 26496 A1 MA26496 A1 MA 26496A1
Authority
MA
Morocco
Prior art keywords
suits
viral
viral suits
Prior art date
Application number
MA25076A
Other languages
English (en)
French (fr)
Inventor
David Walter Barry
Clair Martha Heider St
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9709945.1A external-priority patent/GB9709945D0/en
Priority claimed from GBGB9719883.2A external-priority patent/GB9719883D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA26496A1 publication Critical patent/MA26496A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA25076A 1997-05-17 1998-05-15 Combinaisons anti-virales. MA26496A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9709945.1A GB9709945D0 (en) 1997-05-17 1997-05-17 A novel salt
GBGB9719883.2A GB9719883D0 (en) 1997-09-19 1997-09-19 Antiviral combinations

Publications (1)

Publication Number Publication Date
MA26496A1 true MA26496A1 (fr) 2004-12-20

Family

ID=26311543

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25076A MA26496A1 (fr) 1997-05-17 1998-05-15 Combinaisons anti-virales.

Country Status (12)

Country Link
EP (1) EP0979082A1 (es)
JP (1) JP2001525839A (es)
AR (1) AR012702A1 (es)
AU (1) AU7912398A (es)
BR (1) BR9809127A (es)
CA (1) CA2289655A1 (es)
CO (1) CO4950569A1 (es)
HR (1) HRP980264A2 (es)
MA (1) MA26496A1 (es)
NO (1) NO995620L (es)
PE (1) PE74799A1 (es)
WO (1) WO1998052570A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP990030A2 (en) * 1998-02-17 1999-10-31 Michael B. Maurin Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
EP1332757B1 (en) * 1998-05-27 2012-06-13 Merck Sharp & Dohme Corp. Efavirenz compressed tablet formulation
PE20000559A1 (es) * 1998-05-27 2000-07-05 Merck & Co Inc Formulacion de tabletas comprimidas de efavirenz
US20010014352A1 (en) 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
WO2013111147A1 (en) * 2011-12-19 2013-08-01 Hetero Research Foundation Extended release compositions of nevirapine
US9457028B2 (en) 2013-02-27 2016-10-04 Kyoto University Pharmaceutical composition for use in prevention or treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc

Also Published As

Publication number Publication date
CO4950569A1 (es) 2000-09-01
WO1998052570A1 (en) 1998-11-26
HRP980264A2 (en) 1999-02-28
BR9809127A (pt) 2000-08-01
AR012702A1 (es) 2000-11-08
EP0979082A1 (en) 2000-02-16
PE74799A1 (es) 1999-08-13
CA2289655A1 (en) 1998-11-26
JP2001525839A (ja) 2001-12-11
NO995620D0 (no) 1999-11-16
AU7912398A (en) 1998-12-11
NO995620L (no) 2000-01-14

Similar Documents

Publication Publication Date Title
CU23049A3 (es) Dihidropirimidinas.
TR199800815A3 (tr) Sülfonilaminokarbonasitler.
IT1312540B1 (it) Composto.
TR199800492A3 (tr) Yiyecek takviyesi.
IT1303546B1 (it) Cerniera lampo.
TR199801781A3 (tr) Sapkali tarak.
TR199801657A3 (tr) Havayi emici davlumbaz.
MA26496A1 (fr) Combinaisons anti-virales.
MA24551A1 (fr) W.c.
DE59806150D1 (de) Deckelgarnitur.
IT243482Y1 (it) Sfarinatore intensivo.
ES1036909Y (es) Pupitre infantil.
ES1037395Y (es) Tendedero antilluvia.
ES1038670Y (es) Embarcacion.
ES1037650Y (es) Bicicleta propulsora.
TR199802599A3 (tr) Su kumandali su isiticisi.
ITBO970564A0 (it) Cravatta.
ES1036254Y (es) Gancho-escarpia.
ES1037954Y (es) Cotilo semiexpansivo.
ES1037502Y (es) Hoja - octavilla perfeccionada.
ES1036999Y (es) Abonadora-sembradora.
ES1037763Y (es) Iluminaria.
ES1036787Y (es) Carterita-neceser.
ES1038270Y (es) Anillo-grafo.
IT1295228B1 (it) Radio - bisturi.